Serotonin2A receptor binding potential in people with aggressive and violent behaviour

Journal of Psychiatry and Neuroscience

Volumn 33, Issue 6, 2008, Pages 499-508

  Meyer, Jeffrey H ^a   Wilson, Alan A ^a   Rusjan, Pablo ^a   Clark, Michael ^a   Houle, Sylvain ^a   Woodside, Scott ^a   Arrowood, John ^a   Martin, Krystle ^a   Colleton, Michael ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aggression; Positron emission tomography; Receptors, serotonin, 5 HT2A; Serotonin; Setoperone; Suicide

Indexed keywords

FLUORINE 18; SEROTONIN 2A RECEPTOR; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGE; AGGRESSION; ALCOHOL ABUSE; ANALYSIS OF VARIANCE; ANGER; ARTICLE; CLINICAL ARTICLE; CONDUCT DISORDER; CONTROLLED STUDY; DYSTHYMIA; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; IMAGE ANALYSIS; IMPULSIVENESS; MAJOR DEPRESSION; MALE; OBSESSIVE COMPULSIVE DISORDER; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PSYCHOLOGICAL RATING SCALE; PSYCHOPATHY; RECEPTOR BINDING; RECEPTOR DENSITY; VIOLENCE; AGING; BRAIN; BRAIN LEVEL; IMAGE PROCESSING; MENTAL DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SCINTISCANNING;

ADULT; AGGRESSION; AGING; BRAIN; BRAIN CHEMISTRY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MENTAL DISORDERS; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT2A; VIOLENCE;

EID: 56349150031     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Davidson RJ, Putnam KM, Larson CL. Dysfunction in the neural circuitry of emotion regulation - a possible prelude to violence. Science 2000;289:591-4.
2. Raine A, Lencz T, Bihrle S, et al. Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Arch Gen Psychiatry 2000;57:119-27; discussion 128-9.
3. Siever LJ, Buchsbaum MS, New AS, et al. d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 1999;20:413-23.
4. Bechara A, Damasio H, Damasio AR. Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 2000;10:295-307.
5. Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 1976; 33:1193-7.
6. Träskman L, Asberg M, Sertillson L, et al. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 1981;38:631-6.
7. Brown GL, Ebert MH, Goyer PF, et al. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 1982;139:741-6.
8. Caspi A, McClay J, Moffitt TE, et al. Role of genotype in the cycle of violence in maltreated children. Science 2002;297:851-4.
9. Roth BL, McLean S, Zhu XZ, et al. Characterization of two [3H]ketanserin recognition sites in rat striatum. J Neurochem 1987;49:1833-8.
10. Stockmeier C, Kellar K. In vivo regulation of the serotonin-2 receptor in rat brain. Life Sci 1986;38:117-27.
11. O'Regan D, Kwok RP, Yu PH, et al. A behavioural and neurochemical analysis of chronic and selective monoamine oxidase inhibition. Psychopharmacology (Berl) 1987;92:42-7.
12. Todd KG, McManus DJ, Baker GB. Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain. Cell Mol Neurobiol 1995;15:361-70.
13. Arora RC, Meltzer HY. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 1989;146:730-6.
14. Mann J, Underwood M, Arango V. Postmortem studies of suicide victims. In: Watson SJ, editor. Biology of schizophrenia and affective disorders. Washington: American Psychiatric Press; 1996. p. 197-221.
15. Stanley M, Mann JJ. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983;1:214-6.
16. Mann JJ, Stanley M, McBride PA, et al. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 1986;43:954-9.
17. Arango V, Ernsberger P, Marzuk PM, et al. Autoradiographic demonstration of increased serotonin 5-HT2 and beta- adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990;47:1038-47.
18. Hrdina PD, Demeter E, Vu TB, et al. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res 1993; 614:37-44.
19. Dumais A, Lesage AD, Lalovic A, et al. Is violent method of suicide a behavioral marker of lifetime aggression? Am J Psychiatry 2005; 162:1375-8.
20. Meyer JH, McMain S, Kennedy SH, et al. Dysfunctional attitudes and 5-HT(2) receptors during depression and self-harm. Am J Psychiatry 2003;160:90-9.
21. Frankle WG, Lombardo I, New AS, et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 2005; 162:915-23.
22. Leyton M, Okazawa H, Diksic M, et al. Brain regional alpha[11C] methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry 2001;158:775-82.
23. Sekine Y, Ouchi Y, Takei N, et al. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 2006;63:90-100.
24. Oquendo MA, Russo SA, Underwood MD, et al. Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide. Biol Psychiatry 2006;59:235-43.
25. Meyer JH, Kapur S, Eisfeld B, et al. The effect of paroxetine upon 5-HT(2A) receptors in depression: an [18(F)]setoperone PET imaging study. Am J Psychiatry 2001;158:78-85.
26. Stockmeier CA. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res 2003;37:357-73.
27. Yates M, Leake A, Candy JM, et al. 5HT2 receptor changes in major depression. Biol Psychiatry 1990;27:489-96.
28. Yatham LN, Liddle PF, Dennie J, et al. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. Arch Gen Psychiatry 1999;56:705-11.
29. Maziere B, Crouzel C, Venet M, et al. Synthesis, affinity and specificity of 18F-setoperone, a potential ligand for in-vivo imaging of cortical serotonin receptors. Int J Rad Appl Instrum B 1988;15:463-8.
30. Petit-Taboué MC, Landeau B, Osmont A, et al. Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine18-setoperone kinetic PET data analysis. J Nucl Med 1996;37:95-104.
31. Fischman AJ, Bonab AA, Babich JW, et al. Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent ziprasidone. J Pharmacol Exp Ther 1996;279:939-47.
32. Meyer JH, Kapur S, Houle S, et al. Prefrontal cortex 5-HT2 receptors in depression: an [18(F)]setoperone PET imaging dtudy. Am J Psychiatry 1999;156:1029-34.
33. Schmuck K, Ullmer C, Engels P, et al. Cloning and functional characterization of the human 5-HT2B serotonin receptor. FEBS Lett 1994;342:85-90.
34. Hoyer D, Pazos A, Probst A, et al. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res 1986;376:97-107.
35. First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 1995.
36. Blais MA, Norman DK. A psychometric evaluation of the DSM-IV personality disorder criteria. J Personal Disord 1997;11:168-76.
37. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979;47:343-52.
38. Patton JH, Stanford M, Barratt E. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995;51:768-74.
39. Biaggio MK, Supplee K, Curtis N. Reliability and validity of four anger scales. J Pers Assess 1981;45:639-48.
40. Ichise M, Liow JS, Lu JQ, et al. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 2003;23:1096-112.
41. Kapur S, Jones C, DaSilva J, et al. Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging. Nucl Med Commun 1997;18:395-9.
42. Logan J, Fowler JS, Volkow ND, et al. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996;16:834-40.
43. Turecki G, Brière R, Dewar K, et al. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry 1999;156:1456-8.
44. New AS, Hazlett EA, Buchsbaum MS, et al. Blunted prefrontal cortical 8fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry 2002;59:621-9.
45. Bencherif B, Stumpf MJ, Links JM, et al. Application of MRI-based partial-volume correction to the analysis of PET images of mu-opioid receptors using statistical parametric mapping. J Nucl Med 2004;45:402-8.
46. Bhagwagar Z, Hinz R, Taylor M, et al. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. Am J Psychiatry 2006;163:1580-7.
47. Moffitt TE, Caspi A. Life-course persistent and adolescence-limited antisocial males: longitudinal followup to adulthood. In: Stoff D, Susman E, editors. Developmental psychobiology of aggression. New York: Cambridge University Press; 2005. p. 161-86.
48. Weisstaub NV, Zhou M, Lira A, et al. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 2006; 313:536-40.
49. Palmer AM, Sims NR, Bowen DM, et al. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry 1984;47:481-4.
50. Wallin A, Blennow K, Edman A, et al. Decreased lumbar cerebrospinal fluid levels of monoamine metabolites in vascular dementia. Int Psychogeriatr 1996;8:425-36.
51. Yang Y, Raine A, Lencz T, et al. Volume reduction in prefrontal gray matter in unsuccessful criminal psychopaths. Biol Psychiatry 2005;57:1103-8.
52. Pandey GN, Dwivedi Y, Rizavi HS, et al. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 2002;159:419-29.
53. Yatham LN, Liddle PF, Shiah IS, et al. Brain serotonin2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry 2000;57:850-8.
54. Meltzer CC, Price JC, Mathis CA, et al. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Am J Psychiatry 1999;156:1871-8.
55. Jakab RL, Goldman-Rakic PS. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci U S A 1998;95:735-40.
56. Jacobs B, Driscoll L, Schall M. Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J Comp Neurol 1997;386:661-80.
57. Santana N, Bortolozzi A, Serrats J, et al. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 2004;14:1100-9.
58. Wu C, Singh SK, Dias P, et al. Activated astrocytes display increased 5-HT2a receptor expression in pathological states. Exp Neurol 1999; 158:529-33.
59. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 1997; 54:1081-8.